阿斯利康与甲骨文宣布启动一项全球性人工智能合作,旨在推进临床试验优化,并支持患者取得更好的治疗结果。
阿斯利康与甲骨文宣布启动一项全球性人工智能合作,旨在推进临床试验优化,并支持患者取得更好的治疗结果。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.